|
Net revenue
|
|
$239.4m
|
$269.9m
|
$287.4m
|
$290.3m
|
$310.9m
|
$289.4m
|
$235.1m
|
|
Cost of sales
|
|
$80.3m
|
$91.5m
|
$91.6m
|
$85.4m
|
$77.8m
|
$72.7m
|
$57.5m
|
|
Research and development
|
|
$39.0m
|
$51.7m
|
$61.3m
|
$63.3m
|
$70.3m
|
$67.7m
|
$58.4m
|
|
Total operating costs and expenses
|
|
$222.3m
|
$259.5m
|
$290.4m
|
$318.4m
|
$321.4m
|
$322.3m
|
$259.0m
|
|
Selling and marketing
|
|
$59.9m
|
$57.1m
|
$79.0m
|
$80.8m
|
$74.4m
|
$64.6m
|
$55.5m
|
|
General and administrative
|
|
$16.7m
|
$17.0m
|
$27.9m
|
$40.3m
|
$45.1m
|
$46.1m
|
$45.9m
|
|
Depreciation and amortization
|
|
$25.2m
|
$22.2m
|
$27.4m
|
$35.6m
|
$45.3m
|
$45.4m
|
$38.4m
|
|
Restructuring and related
|
|
$1.2m
|
$20.1m
|
$3.1m
|
$13.0m
|
$8.6m
|
$25.7m
|
$3.5m
|
|
Loss from operations
|
|
$17.1m
|
$10.3m
|
($3.0m)
|
($28.1m)
|
($10.5m)
|
($32.9m)
|
($23.9m)
|
|
Change in fair value of warrant liabilities
|
|
$0
|
$0
|
$13.9m
|
$1.0m
|
$2.6m
|
$856k
|
$156k
|
|
Change in fair value of contingent consideration
|
|
—
|
—
|
—
|
—
|
—
|
($85k)
|
($5.0m)
|
|
Interest income, net
|
|
—
|
—
|
—
|
—
|
$4.9m
|
$4.9m
|
$2.9m
|
|
Loss before income taxes
|
|
$17.6m
|
$11.1m
|
$10.5m
|
($23.6m)
|
($2.5m)
|
($27.3m)
|
($26.7m)
|
|
Net loss
|
|
$13.6m
|
$12.8m
|
$10.7m
|
($17.8m)
|
($19.4m)
|
($28.7m)
|
($28.6m)
|
|
Total other (loss) income, net
|
|
$452k
|
$787k
|
$13.5m
|
$4.5m
|
$8.0m
|
$5.6m
|
($2.8m)
|
|
Basic (USD per share)
|
|
$0.15
|
$0.14
|
$0.10
|
($0.14)
|
($0.15)
|
($0.22)
|
($0.23)
|
|
Diluted (USD per share)
|
|
$0.14
|
$0.12
|
$0.09
|
($0.14)
|
($0.15)
|
($0.22)
|
($0.23)
|
|
Other expense, net
|
|
$716k
|
$929k
|
($229k)
|
$1.5m
|
$513k
|
($182k)
|
($910k)
|
|
Income tax expense
|
|
($4.0m)
|
$1.7m
|
$258k
|
$5.8m
|
($16.9m)
|
($1.4m)
|
($1.9m)
|